Related Experiment Video
Updated: Sep 1, 2025

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.4K
Risk Factors for Cervical Lymph Node Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma
Sandeep Kumar Parvathareddy1, Abdul K Siraj1, Padmanaban Annaiyappanaidu1
1Human Cancer Genomic Research, King Faisal Specialist Hospital and Research Centre, P.O. Box 3354, Riyadh 11211, Saudi Arabia.
Journal of Clinical Medicine
|August 12, 2022
Summary
Bilateral tumors and gross extrathyroidal extension independently predict lymph node metastasis in Middle Eastern papillary thyroid microcarcinoma patients. Lymph node metastasis is linked to shorter recurrence-free survival.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Papillary thyroid microcarcinoma (PTMC) usually has an excellent prognosis.
- However, some PTMC cases involve lymph node metastasis (LNM) and local recurrence.
- PTMC in Middle Eastern populations exhibits unique characteristics, necessitating specific risk factor exploration.
Purpose of the Study:
- To investigate factors influencing LNM in Middle Eastern PTMC patients.
- To assess the impact of LNM on patient outcomes.
- To identify predictors for LNM in this demographic.
Main Methods:
- Retrospective analysis of 226 PTMC cases.
- Evaluation of clinico-pathological and molecular characteristics against LNM.
- Multivariate logistic regression and Cox proportional hazards models were employed.
Main Results:
- LNM rate was 43.8% (99/226).
- Bilaterality, multifocality, gross extrathyroidal extension (ETE), and intermediate-to-high ATA risk were associated with LNM.
- Bilaterality and gross ETE were identified as independent predictors of LNM.
Conclusions:
- Bilaterality and gross ETE are independent risk factors for LNM in Saudi PTMC patients.
- LNM is associated with significantly shorter recurrence-free survival.
- Identifying these risk factors aids in personalized clinical management of PTMC.
Related Concept Videos
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K

